Drug Development

Once a lead molecule has been identified through the drug discovery process, drug development focuses on bringing a new pharmaceutical medicine to market. It may include pre-clinical research on microbes and animals, as well as submitting for regulatory status, such as an investigational new drug application with the US Food and Drug Administration to begin human clinical trials.

  • Target identification and Validation
  • Hit identification and Validation
  • Moving from a hit to a lead
  • Lead Optimization
  • Late Lead Optimization

Related Conference of Drug Development

April 14-15, 2025

18th European Biosimilars Congress

Paris, France
April 14-15, 2025

35th Annual European Pharma Congress

Paris, France
April 24-25, 2025

18th World Drug Delivery Summit

London, UK
May 05-06, 2025

19th World Drug Delivery Summit

Vancouver, Canada
June 16-17, 2025

3rd Global Online Summit on Nanoscience and Nanotechnology

Zurich, Switzerland
June 23-24, 2025

38th World Congress on Pharmacology

Paris, France
August 18-19, 2025

40th World Congress on Pharmacology and Therapeutics

Valencia, Spain
September 22-23, 2025

Pharma Biotech Expo

Toronto, Canada
September 23-24, 2025

10th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
November 27-28, 2025

4th World Congress on Precision and Personalized Medicine

Zurich, Switzerland
November 27-28, 2025

4th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
November 27-28, 2025

13th International Conference on Clinical Trials

Amsterdam, Netherlands

Drug Development Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in